Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Nuclear Medicine Communications|December 1, 1984
Imaging of phaeochromocytoma and adrenal medulla with 123I-meta-iodobenzyl guanidineT Horne, L A Hawkins, K E Britton, et al.Neuroendocrinology|January 1, 1987
Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in manS Al-Damluji, L Perry, S Tomlin, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1978
Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in manM O Thorner, S M Ryan, J A Wass, et al.The Journal of Clinical Endocrinology and Metabolism|April 1, 1993
Xp22.3 deletions in isolated familial Kallmann's syndromeJ P Hardelin, J Levilliers, J Young, et al.Human Molecular Genetics|April 1, 1993
Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndromeJ P Hardelin, J Levilliers, S Blanchard, et al.Psychoneuroendocrinology|January 1, 1990
Endogenous opioids modulate the cardiovascular response to mental stressM Morris, P Salmon, H Steinberg, et al.Alimentary Pharmacology & Therapeutics|February 4, 2003
Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experienceJ Garland, J R Buscombe, C Bouvier, et al.The New England Journal of Medicine|July 27, 1989
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11R V Thakker, P Bouloux, C Wooding, et al.Journal of Medical Genetics|October 1, 1993
Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinismA Meindl, D Hosenfeld, W Brückl, et al.Clinical Science (London, England : 1979)|November 1, 1984
The role of opioid peptides in the hormonal responses to acute exercise in manA Grossman, P Bouloux, P Price, et al.Pageof 5